CapsoVision
Company Snapshot
CapsoVision is a commercial-stage medical technology company that develops advanced imaging and artificial intelligence technologies for capsule endoscopy solutions. The company's products are designed to identify abnormalities in the gastrointestinal tract for diagnostic and screening purposes. CapsoVision's key value proposition lies in its wire-free capsule endoscopy solution, which offers a non-invasive and cost-effective method for visualizing the small-bowel mucosa.
Key Financials
| Metric | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | $11.8M | $9.8M | Not provided |
| YoY Growth | +20.4% | - | - |
| Adjusted Net Income | Not provided | Not provided | Not provided |
S-1 Highlights
Market & Competition
CapsoVision operates in the capsule endoscopy market, which is estimated to reach approximately $335 million globally by 2030. The company competes with other capsule endoscopy providers targeting gastrointestinal medical indications.
Use of Proceeds
CapsoVision plans to use the IPO proceeds to expand its sales and marketing efforts, enhance its product offerings, and support its growth strategies.
Key Risk Factors
- ●The company may face delays in obtaining FDA 510(k) clearance for its products, which could impact its ability to generate revenue.
- ●CapsoVision's success depends on its ability to compete effectively against established competitors with existing FDA-cleared products.
Reported Broker Availability
Reported by users or publicly disclosed. Information is for reference only.